Financials Akso Health Group

Equities

AHG

US98422P1084

Internet Services

Market Closed - Nasdaq 04:30:00 2024-04-26 pm EDT 5-day change 1st Jan Change
0.7986 USD +3.71% Intraday chart for Akso Health Group -19.33% +7.92%

Valuation

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Capitalization 1 542.4 163.8 20.45 30.09 38.64 8.117
Enterprise Value (EV) 1 409.8 126.5 30.31 27.93 53.92 9.879
P/E ratio 8.26 x 33.4 x -0.29 x -0.82 x -1.99 x -4.31 x
Yield 2.39% - - - - -
Capitalization / Revenue 5.06 x 2.67 x 1.79 x 17.1 x 6.12 x 0.62 x
EV / Revenue 3.82 x 2.06 x 2.65 x 15.9 x 8.54 x 0.75 x
EV / EBITDA 5.39 x 23 x -0.84 x -1.03 x -3.57 x -0.69 x
EV / FCF 8.96 x 59.1 x -0.76 x 6.93 x -2.29 x 0.86 x
FCF Yield 11.2% 1.69% -131% 14.4% -43.6% 117%
Price to Book 3.87 x 1.3 x 0.43 x 1.66 x 3.15 x 0.93 x
Nbr of stocks (in thousands) 15,986 16,352 16,227 17,098 22,866 22,866
Reference price 2 33.93 10.02 1.260 1.760 1.690 0.3550
Announcement Date 7/30/18 7/31/19 8/14/20 7/28/21 12/29/22 7/14/23
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Net sales 1 107.3 61.33 11.44 1.755 6.311 13.18
EBITDA 1 76.05 5.505 -36.25 -27.13 -15.12 -14.25
EBIT 1 75.88 5.098 -36.83 -27.15 -15.13 -14.27
Operating Margin 70.74% 8.31% -322.05% -1,547.05% -239.79% -108.23%
Earnings before Tax (EBT) 1 76.54 7.405 -66.93 -31.07 -16.72 -13.07
Net income 1 65.48 5.533 -71.2 -34.83 -16.85 -1.36
Net margin 61.05% 9.02% -622.63% -1,984.52% -267.01% -10.32%
EPS 2 4.110 0.3000 -4.381 -2.139 -0.8480 -0.0823
Free Cash Flow 1 45.76 2.141 -39.83 4.03 -23.51 11.54
FCF margin 42.66% 3.49% -348.34% 229.61% -372.55% 87.53%
FCF Conversion (EBITDA) 60.17% 38.9% - - - -
FCF Conversion (Net income) 69.88% 38.7% - - - -
Dividend per Share 2 0.8100 - - - - -
Announcement Date 7/30/18 7/31/19 8/14/20 7/28/21 12/29/22 7/14/23
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Net Debt 1 - - 9.87 - 15.3 1.76
Net Cash position 1 133 37.4 - 2.16 - -
Leverage (Debt/EBITDA) - - -0.2722 x - -1.011 x -0.1236 x
Free Cash Flow 1 45.8 2.14 -39.8 4.03 -23.5 11.5
ROE (net income / shareholders' equity) 80.1% 4.15% -81.6% -96.5% -114% -124%
ROA (Net income/ Total Assets) 49.3% 1.89% -18.3% -30.3% -23% -21.4%
Assets 1 132.7 292.7 389.2 115.1 73.37 6.35
Book Value Per Share 2 8.760 7.710 2.960 1.060 0.5400 0.3800
Cash Flow per Share 2 8.300 3.500 0.6700 0.9300 0.9600 0.3500
Capex 1 0.46 0.94 0.31 - 0 -
Capex / Sales 0.43% 1.54% 2.75% - 0.08% -
Announcement Date 7/30/18 7/31/19 8/14/20 7/28/21 12/29/22 7/14/23
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Equities
  3. AHG Stock
  4. Financials Akso Health Group